Prevalence of metabolic syndrome (MS) in the clinical practice is still debated, due to different diagnostic criteria, target populations and clinical settings. Thus, the main purposes of the study were: (I) to evaluate prevalence of MS; (II) to estimate prevalence of additional cardiovascular (CV) risk factors and concomitant conditions in patients with MS followed by general practitioners (GPs) in Italy.

Prevalence of metabolic syndrome in the clinical practice of general medicine in Italy

BRUNO, Graziella;
2015-01-01

Abstract

Prevalence of metabolic syndrome (MS) in the clinical practice is still debated, due to different diagnostic criteria, target populations and clinical settings. Thus, the main purposes of the study were: (I) to evaluate prevalence of MS; (II) to estimate prevalence of additional cardiovascular (CV) risk factors and concomitant conditions in patients with MS followed by general practitioners (GPs) in Italy.
2015
5
4
271
279
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536471/
Metabolic syndrome (MS); cardiovascular risk; diabetes; hypercholesterolemia; hypertension
Tocci, Giuliano; Ferrucci, Andrea; Bruno, Graziella; Mannarino, Elmo; Nati, Giulio; Trimarco, Bruno; Volpe, Massimo
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1531159
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 13
social impact